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ABSTRACT
Aim: to investigate the thrombolytic activity of Lagerstroemia speciosa 
leaf extract. 
Methods: thrombolytic activity assayed by an in vitro thrombolytic 
activity model performed on 10 apparently healthy subjects (both 
male and female), where the clot lysis ability of methanolic extract of 
Lagerstroemia speciosa leaves compared with Streptokinase a positive 
control and saline water as a negative control.
Result: Fraction of methanolic extract of Lagerstroemia speciosa 
exhibited significant percentage (%) of clot lysis of 25.42% compared 
to positive control streptokinase of 31.06% loss of clot while the 
negative control saline water showed 3.81% clot lysis ability.
Conclusion: The present investigation revealed that the methanol extracts 
of the leaves of Lagerstroemia speciosa possess potent thrombolytic 
properties may refer to the treatment of cardiovascular diseases. 
Keywords: Lagerstroemia speciosa (Lf
l
), Thrombolytic activity, Fibrinolytic, Streptokinase
INTRODUCTION 
According to WHO-Cardiovascular diseases (CVDs) 
are maladies of the heart and blood vessels, includ-
ing coronary heart disease and cerebrovascular 
disease and other dysfunctional conditions. Around 
17.5 million people, an estimated 31% of all deaths 
worldwide from cardiovascular diseases (CVDs). 
In addition, most of the cardiovascular diseases 
(CVDs) deaths are due to strokes and heart attacks. 
Cardiovascular diseases are the number 1 cause of 
death globally more than from any other cause which 
increasing at an alarming rate in the recent years.1
The main reason of cardiovascular disease is 
thrombus (blood clot) that actually obstructs the 
blood flow by blocking the blood vessel, therefore 
depriving tissues of normal blood flow and oxygen 
that consequences yield necrosis of the tissue in 
those areas and can lead to acute myocardial infarc-
tion and ischemic stroke and leading to death.2 
Other than surgical mediations to deliver a new 
blood supply, the only treatment obtainable is the 
administration of thrombolytic or fibrinolytic drug 
use to dissolve the blood clot or to dissolve throm-
bin in acutely occluded coronary arteries, thereby 
to restore blood supply to ischemic myocardium, to 
limit necrosis and to improve prognosis.3,4
In the management of thrombosis, Thrombolytic/
fibrinolytic agents are used to dissolve the clots.5 
As tissue plasminogen activator (t-PA), Urokinase 
(UK), streptokinase (SK)6 are the Thrombolytic 
agents are used all over the world for the treatment7 
However their use is concomitant with hyper risk of 
haemorrhage8 anaphylactic reaction and lacks spec-
ificity. Remarkable efforts have been made towards 
the discovery and development of natural constitu-
ents from various plant and animal sources which 
have anti-platelet9,10 anticoagulant10 antithrombotic 
and thrombolytic activity.11
From that, point of views we selected 
Lagerstroemia speciosa (popularly called as “Jarul” 
in West Bengal, India, and in Bangladesh) belongs 
to the family of Lythraceae for our research interest. 
It is known as Pride of India, and called Queen’s 
Flowers or Queen Crape Myrtle in English and 
banabá plant in the Philippines.
In the past 10 years, banaba extracts subjected 
for chemicals compound isolation as well as phar-
macological activity that have attracted significant 
scientific attention.
Lagerstroemia speciosa are also known to have, 
diuretic, anti-obesity and anti-gout activity. The 
leaves extract also used in the Asian subcontinent 
for the treatment of diabetes and kidney disease.12,13 
previous studies evaluated the cytotoxic, antibacte-
rial and antiviral activity and exhibited prominent 
activities.14 Even the roots and flower petals of 
Lagerstroemia speciosa showed hepatoprotective 
activity.15 
However, there are no established medicinal 
claims about the clot lysis activity of this plant. By 
considering all potent remedial properties, and 
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huge range of potent chemical compounds isola-
tion, we made attempt to investigate the methan-
olic extract of Lagerstroemia speciosa leaves for its 
thrombolytic ability.
METHODS AND MATERIALS 
Collection & Identification 
The leaves of Lagerstroemia speciosa. (Family: 
Lythraceae) were collected during the month of 
November 2016 from the area of Dohar, Nababganj, 
Dhaka Division, Bangladesh. The plant was 
mounted on paper and a taxonomist of Bangladesh 
National Herbarium (BNH), Mirpur, Dhaka taxo-
nomically identified the species. The voucher spec-
imen of the plant has been deposited and preserved 
in BNH library for further collection and reference 
and an accession no was provided as DACB -43543.
Plant Extract preparation 
The collected leaves washed with fresh water to 
avoid undesirable dirt and dried under shades for 
a week then powdered into a coarse powder with 
the help of a suitable grinder .By using soxhlet 
apparatus about 287 gm/each of leaves powder was 
refluxed with methanol. The final extract collected 
and successively filtered through filter paper and 
finally got 22.88 gm of evaporated greenish extract 
as yield value 7.97%.
Instruments & Chemicals 
Soxhlet apparatus, Eppendorf tubes, Syringe, 
Methanol (Analytical grade) Streptokinase 
(15, 00,000 I.U) - Beacon pharmaceutical Ltd, 
Bangladesh .Additional required chemicals (analyt-
ical grade) for this present study were provided by 
laboratory of department of Pharmacy.
Blood specimen collection 
3ml of Blood was drawn from healthy human 
volunteers (n = 10 both Male & Female; Age=23-25) 
without a history of oral contraceptive or anticoag-
ulant therapy for 2 weeks. 
Statement on informed consent of the 
donors
The title of the research project, purpose of the 
research as well as name and detail contact of 
investigators was provided to the volunteer donors 
(students of the departments) as a consent form. 
Probable discomforts, damage/injuries, or difficulty 
associated with donors in this study was added as 
informed consent declaration. 
Discretion statement was included in the consent 
form in the way that “confidentiality will be respected 
and no evidence that discloses the individuality of 
the participant will be released or published without 
permission. For further query about this study, detail 
contact of investigators was provided to the donors. 
The consent form was accomplished with major 
questions on above disclosures in Yes/NO form 
followed by the signature (with date) of the donor.16
Preparation of Positive Control (Standard) 
and Negative Control:
Streptokinase (15, 00,000 I.U) used as a standard 
whttps://lyricsbanglasong.wordpress.com/hich 
was collected from Beacon pharmaceutical Ltd, 
Bangladesh. 5mL normal saline was added to strep-
tokinase vial and was mixed properly and marked 
as positive control.17 As a negative control Saline 
water used in thrombolytic assay.
Preparation of Extract Solution for 
Thrombolytic Test
10 mg of the extract was suspended in 10ml distilled 
water and shaken vigorously on a vortex mixer. Then 
the suspension was kept overnight and decanted to 
remove the soluble supernatant, which was filtered 
through a filter paper .The solution, was then ready 
for in vitro evaluation of clot lysis activity.
Statistical Analysis
All the obtained data from in vivo experiments 
were analyzed using SPSS Software (SPSS for 
Windows, Version 20.0, IBM Corporation, USA) 
and Microsoft Office Excel 2007. All values are 
expressed as mean ± SEM. P value evaluated by 
One-way ANOVA. Data are expressed as mean ± 
standard deviation. The mean difference between 
positive and negative control was considered signif-
icant at p < 0.05.
Test Procedure for In vitro thrombolytic 
activity test:
For the healing of acute myocardial infarction 
(heart attack), pulmonary embolism, and arterial 
thrombo-embolism, streptokinase performed 
as a thrombolytic agent. Streptokinase is an 
enzyme originated from Gram-positive bacteria 
-Streptococcus. It forms a complex with plasmino-
gen, which then converts plasminogen to plasmin. 
Plasmin breaks down clots as well as fibrinogen and 
other plasma proteins.18
The thrombolytic activity of the extract was 
evaluated by comparing with streptokinase 
(Plasmin activator) as the standard. Empty 
Eppendorf tubes were weighed as W1. From the 
collected blood sample 500μL of fresh blood 
were transferred to the pre weighed Eppendorf 
tubes (500μL/tube) and incubated at 37°C for 
45 minutes for the development of clot, the pale 
yellow plasma fluid or serum was completely 
removed by the syringe, without the disruption of 
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clot. The tube with the removed serum having the 
clot was again weighed as W2.
Clot weight WC =  Weight of clot containing tube W2 
– Weight of tube alone W1
The clot containing eppendorf tubes was appro-
priately labeled. 100μL of the methanolic extract 
solution as experimental solution, 100μL of strep-
tokinase (1500000 I.U/ml) as positive control, and 
as negative control 100μL of saline were added to 
the labeled tubes. 
After incubation for 90 minutes at 37°C, 
observed for the lysis of clot. The released fluid were 
withdrawn from each tubes and weighed as WRC’’ 
to see the  difference in weight after clot disruption. 
Difference obtained in weight, taken before and 
after clot, lysis was expressed as percentage of clot 
lysis as shown below:
% of clot lysis =  (Weight of released clot RC /Clot 
weight WC) × 100
Or 
Percentage clot lysis =  (weight of the clot after lysis 
by sample and removal of 
serum/weight of the clot 
before lysis by sample) ×100.
Result of Thrombolytic Assay 
To evaluate Thrombolytic effect addition of 
100μl Streptokinase, (as positive control) saline 
water (negative control) and Lagerstroemia 
speciosa (Lfl) to the clots along with 90 minutes 
of incubation at 37°C, showed (31.08 ± 1.85)%, 
(25.42  ± 2.98)% and (3.80±1.07)% clot lysis 
activity respectively. 
Which is tabulated in (Table: 1 and Figure: 1)
The mean differences between positive control, 
negative control and sample ware considered statis-
tically significant at p < 0.05 level. 
Table 1  ANOVA done in SPSS Version 20.0 followed by Dunnet T Test; ***indicate P < 0.05; values are expressed as 
Mean ± SD (N=10)
Lagerstroemia speciosa (Lfl) Streptokinase Saline Water
SL No  WC WRC RC
% of Clot 
lysis = RC/
WC ×100 WC WRC RC
% of Clot 
lysis=RC/
WC ×100 WC WRC RC
% of Clot 
lysis = RC/
WC ×100
1 0.306 0.221 0.085 27.78 0.352 0.238 0.114 32.38 0.523 0.511 0.012 2.29
2 0.458 0.341 0.117 25.55 0.472 0.329 0.143 30.29 0.486 0.471 0.015 3.08
3 0.446 0.338 0.108 24.22 0.533 0.377 0.156 29.27 0.477 0.463 0.014 2.94
4 0.523 0.418 0.105 20.01 0.387 0.265 0.122 31.52 0.382 0.361 0.021 5.49
5 0.378 0.265 0.113 29.89 0.365 0.243 0.122 33.42 0.411 0.394 0.017 4.13
6 0.413 0.324 0.089 21.55 0.438 0.318 0.120 27.40 0.499 0.484 0.015 3.01
7 0.467 0.354 0.113 24.20 0.331 0.223 0.108 32.63 0.365 0.351 0.014 3.68
8 0.344 0.251 0.093 27.03 0.298 0.201 0.097 32.55 0.299 0.283 0.016 5.35
9 0.399 0.292 0.107 26.82 0.378 0.259 0.119 31.48 0.320 0.305 0.015 4.68
10 0.298 0.217 0.081 27.18 0.361 0.253 0.108 29.92 0.378 0.365 0.013 3.44
Mean ±SD SEM
95% Confidence
Lower Bound Upper Bound
Lagerstroemia speciosa (Lfl) 25.42 ± 2.98*** 0.945 23.28 27.56
Streptokinase 31.08±1.85 0.585 29.76 32.41
Saline Water 3.80±1.07 0.340 3.03 4.57
Notes: WC= Wt of Clot; WRC= Wt of clot after incubation with applied sample; RC = Wt loss after administration. *** = Level of significance; sample Lagerstroemia 
speciosa (Lfl) leaves showed significant clot lysis ability in compared with positive control (Streptokinase) and negative control (Saline Water)
Figure 1  Comparative thrombolytic (as Clot lysis 
percentage (%)) effect of Lagerstroemia 
speciosa (Lfl): 25.42%, streptokinase: 
31.086% and Saline water: 3.809%
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DISCUSSION
Plants derived chemical compounds used for 
mitigating various diseases from the ancient era. 
Today’s pharma industry invests millions for drug 
development purpose, whereas many drugs have 
origins to plant sources. A distinct number of 
plant-originated compounds having anticoagulant, 
antiplatelet and fibrinolytic activity and leads to 
prevention of coronary events and stroke. 
Thrombo embolic disorders such as pulmo-
nary emboli, deep vein thrombosis, strokes and 
heart attacks are the main causes of morbidity 
and mortality in developed countries. All avail-
able thrombolytic agents still have a significant 
shortcoming, which actually indicate the necessity 
of safest remedy like Plant-based drug. Current 
 phyto-pharmacological studies propose remedial 
estimations of these natural preparations, including 
glowering of blood pressure and lipids, thrombolytic 
activity and the promotion of microcirculation.19,20
The previous randomized research21,22-25 claimed 
that Lagerstroemia speciosa leaves have distinct 
pharmacological properties like antidiabetic, anal-
gesic, antimicrobial, antibiotic, hepatoprotective 
etc. The present investigation intended to assess the 
thrombolytic and/or fibrinolytic effect (s) of meth-
anolic extract of chosen plants leaves. 
In our in vitro thrombolytic assay, the compar-
ison of positive control with negative control 
clearly established that clot dissolution does not 
enhance when saline water was added to the clot. 
When Lagerstroemia speciosa (Lfl) leaves extract 
compared with the clot lysis percentage obtained 
through SK and saline water, a significant (p value 
< 0.05) thrombolytic activity was observed.
CONCLUSION
This work has demonstrated that the leaves of 
L.  speciosa possess significant (P <0.05) thrombo-
lytic potentiality, that may establish a new source 
of medicine for coronary heart disease and cere-
brovascular treatment. However, we do believe 
this plant deserve further scientific approaches to 
authenticate to understand the exact mechanisms 
of such actions. Through In silico analysis, each 
isolated bioactive unit of L. speciosa leaves can be 
counted for precise evaluation.
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